Kneeland C. Youngblood joined the Board in 2018 as a director. Mr. Youngblood has served as a founding partner, chairman and CEO of Pharos Capital Group, LLC, a private equity firm that invests in the healthcare sector. He has previously served as a director of Mallinckrodt Pharmaceuticals, a specialty pharmaceutical company, a director of TPG Pace SPACs and a trustee of the Dallas Police and Fire Pension Fund.

Formerly, he served on the board of directors of The Gap Inc., Burger King Holdings, Inc. and Starwood Hotels & Resorts Worldwide, Inc. Mr. Youngblood graduated from Princeton University in 1978 with a Bachelor of Arts and earned a Doctor of Medicine from the University of Texas, Southwestern Medical School in 1982.